# A cell atlas of multiple liver organoids and the fetal liver based on scRNA-seq

**Authors:** Qinfeng Ma, Xu Zhang, Jianbo Pan

PMC · DOI: 10.1016/j.isci.2026.114955 · iScience · 2026-02-07

## TL;DR

This study creates a detailed cell atlas of liver organoids and compares them to fetal liver tissue to understand development and improve culture methods.

## Contribution

The paper introduces a unified single-cell RNA-seq atlas of liver organoids across multiple culture protocols and compares them to fetal liver data.

## Key findings

- Liver organoids show diverse cellular compositions depending on culture conditions.
- Organoids lack representation of hematopoietic lineages compared to fetal liver tissue.
- NOTCH, VEGF, HGF, and WNT signaling are prominent in liver organoids.

## Abstract

Understanding the cellular characteristics and regulatory networks of cells during the growth of human liver organoids is crucial for comprehending liver development and function. However, a comprehensive cell atlas of liver organoids spanning multiple culture protocols is still lacking. To address this gap, we integrated scRNA-seq datasets of liver organoids from public repositories with published human fetal liver datasets, constructing a unified liver organoid cell atlas comprising 217,025 high-quality cells. This atlas captures diverse cellular compositions across culture conditions of liver organoids. Comparative analyses revealed deficiencies in hematopoietic lineage representation in organoids relative to fetal tissues. Subpopulation and pseudotime analyses provided insights into hepatoblast fate transitions, while cell-cell communication analysis highlighted prominent NOTCH, VEGF, HGF, and WNT signaling activities in organoids. Together, our study delineates differences between liver organoids and fetal tissues and enables systematic comparison across culture protocols, providing a framework for protocol evaluation and optimization.

•Single-cell transcriptomic atlas of liver organoids was constructed across culture protocols•A systematic comparison was performed among protocols and between organoids and fetal liver•Cell trajectory and communication were analyzed to guide culture system optimization

Single-cell transcriptomic atlas of liver organoids was constructed across culture protocols

A systematic comparison was performed among protocols and between organoids and fetal liver

Cell trajectory and communication were analyzed to guide culture system optimization

Medicine; Integrative aspects of cell biology; Transcriptomics

## Linked entities

- **Proteins:** Notch (neurogenic locus notch homolog), VEGFA (vascular endothelial growth factor A), HGF (hepatocyte growth factor), Wnt (protein Wnt-2)

## Full-text entities

- **Genes:** DLK1 (delta like non-canonical Notch ligand 1) [NCBI Gene 8788] {aka DLK, DLK-1, Delta1, FA1, PREF1, Pref-1}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, FGF4 (fibroblast growth factor 4) [NCBI Gene 2249] {aka FGF-4, HBGF-4, HST, HST-1, HSTF-1, HSTF1}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, CYP3A7 (cytochrome P450 family 3 subfamily A member 7) [NCBI Gene 1551] {aka CP37, CYPIIIA7, P-450(HFL33), P-450111A7, P450-HFLA, P450HLp2}, RSPO1 (R-spondin 1) [NCBI Gene 284654] {aka CRISTIN3, RSPO}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, ATF5 (activating transcription factor 5) [NCBI Gene 22809] {aka ATFX, HMFN0395}, EPOR (erythropoietin receptor) [NCBI Gene 2057] {aka EPO-R}, OSM (oncostatin M) [NCBI Gene 5008], Prox1 (prospero homeobox 1) [NCBI Gene 19130] {aka A230003G05Rik, PROX-1}, PTN (pleiotrophin) [NCBI Gene 5764] {aka HARP, HB-GAM, HBBM, HBGF-8, HBGF8, HBNF}, ACTA2 (actin alpha 2, smooth muscle) [NCBI Gene 59] {aka ACTSA, SMDYS}, NUCLEOLIN (nucleolin multifunctional protein) [NCBI Gene 4691] {aka C23, NCL, Nsr1}, DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567] {aka AOS6, delta4, hdelta2}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, Nes (nestin) [NCBI Gene 18008] {aka ESTM46, Ifaprc2, Marc2, RC2}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, MDK (midkine) [NCBI Gene 4192] {aka ARAP, MK, NEGF2}, Jag1 (jagged 1) [NCBI Gene 16449] {aka ABE2, Gena228, Gsfabe2, Htu, Ozz, Ser-1}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Lama5 (laminin, alpha 5) [NCBI Gene 16776] {aka [a]5, laminin-511, mKIAA0533}, SPINK1 (serine peptidase inhibitor Kazal type 1) [NCBI Gene 6690] {aka PCTT, PSTI, Spink3, TATI, TCP}, NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, TACSTD2 (tumor associated calcium signal transducer 2) [NCBI Gene 4070] {aka EGP-1, EGP1, GA733-1, GA7331, GP50, M1S1}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159] {aka CD140B, IBGC4, IMF1, JTK12, KOGS, OPDKD}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, Gata6 (GATA binding protein 6) [NCBI Gene 14465] {aka GATA-6}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, Esam (endothelial cell-specific adhesion molecule) [NCBI Gene 69524] {aka 2310008D05Rik, Esam1, W117m}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}
- **Diseases:** hypoxic (MESH:D002534), toxicity (MESH:D064420), RA-deficient (MESH:D015223)
- **Chemicals:** oxygen (MESH:D010100), RA (MESH:D014212), 9-cis-retinoic acid (MESH:D000077556), hydrogen peroxide (MESH:D006861), bile acid (MESH:D001647), carbohydrates (MESH:D002241), dexamethasone (MESH:D003907), urea (MESH:D014508), lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927097/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927097/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927097/full.md

---
Source: https://tomesphere.com/paper/PMC12927097